Autoimmune Skin Diseases: Innovations, Challenges, and Opportunities
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 25 October 2025 | Viewed by 421
Special Issue Editor
Special Issue Information
Dear Colleagues,
The advent of biologic therapies has transformed the management of common inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa, leading to significant changes in drug utilization. While these treatments have greatly improved patient outcomes, they also present challenges, including an increasing economic burden on healthcare systems. This Special Issue will explore these challenges while addressing specific shifts in healthcare access, such as hospitalization rates, physician visits, and the emergence of comorbid conditions. Additionally, we will examine novel approaches to photodermatoses, such as solar urticaria and collagen vascular diseases, driven by advances in research on immunopathogenesis. A key focus will also be placed on recent developments in targeted therapies for immunobullous disorders and graft-versus-host disease, opening up new avenues for precision medicine. By integrating research on disease mechanisms, innovative treatment strategies, and healthcare impacts, this Special Issue will foster conversations around optimizing patient care and resource allocation in autoimmune dermatology.
Dr. Shany Sherman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- healthcare utilization
- inflammatory skin diseases
- photodermatoses
- collagen vascular disease
- immunobullous disorders
- graft-versus-host disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
